StockData
Silo Pharma, Inc. logo

Silo Pharma, Inc. (SILO) stock

SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$1.71+0.14 (+8.57%)

Close on Nov 17, 2026Market cap $2.72MP/E –Yield –

Silo Pharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Silo Pharma's price to sales ratio was 38.4× on Nov 11, 2026, against 67.5× a year earlier. Over the last 4 years it ranged from 25.7× to 386.0×, with a median of 67.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202638.4×−10.9
2025Dec 31, 202549.3×−6.0
2024Dec 31, 202455.4×+5.7
2023Dec 29, 202349.7×−78.5
2021Oct 29, 2021128.2×−257.8
2020Oct 30, 2020386.0×–

More Silo Pharma figures

See a number that looks wrong?